ASEP Medical Holdings Inc. SEPSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.43% | 14.11% | 11.00% | 18.35% | 70.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.43% | 14.11% | 11.00% | 18.35% | 70.84% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 14.43% | 14.11% | 11.00% | 18.35% | 70.84% |
| SG&A Expenses | -14.81% | -34.56% | -28.34% | -43.08% | -50.33% |
| Depreciation & Amortization | -42.22% | -44.21% | -46.48% | -36.89% | -25.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.87% | -36.44% | -33.31% | -42.13% | -45.92% |
| Operating Income | 25.92% | 40.79% | 36.91% | 45.50% | 49.76% |
| Income Before Tax | 50.07% | 47.32% | 45.86% | -127.38% | -108.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.48% | 47.32% | 45.86% | -127.38% | -108.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -53.15% | -52.94% | -53.45% | 461.06% | 422.57% |
| Net Income | 48.76% | 43.66% | 40.91% | -64.47% | -50.33% |
| EBIT | 25.92% | 40.79% | 36.91% | 45.50% | 49.76% |
| EBITDA | 16.58% | 39.36% | 31.93% | 49.08% | 57.99% |
| EPS Basic | 64.37% | 60.80% | 57.36% | -43.24% | -28.69% |
| Normalized Basic EPS | -76.91% | -74.49% | -80.73% | 240.70% | 211.91% |
| EPS Diluted | 64.37% | 60.80% | 57.36% | -43.24% | -28.69% |
| Normalized Diluted EPS | -76.91% | -74.49% | -80.73% | 240.70% | 211.91% |
| Average Basic Shares Outstanding | 39.64% | 42.30% | 35.86% | 28.82% | 22.31% |
| Average Diluted Shares Outstanding | 39.64% | 42.30% | 35.86% | 28.82% | 22.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |